# Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?

> **NCT01312272** · NA · COMPLETED · sponsor: **VA Greater Los Angeles Healthcare System** · enrollment: 24 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Inactive placebo nasal spray

## Key facts

- **NCT ID:** NCT01312272
- **Lead sponsor:** VA Greater Los Angeles Healthcare System
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01312272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01312272, "Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01312272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*